Pulmonary Embolism in Patients with CKD and ESRD

Abstract

SummaryBackground and objectives CKD and ESRD are growing burdens. It is unclear whether these conditions affect pulmonary embolism (PE) risk, given that they affect both procoagulant and anticoagulant factors. This study examined the frequency and associated outcomes of PE in CKD and ESRD.Design, setting, participants, & measurements The Healthcare Cost and Utilization Project's Nationwide Inpatient Sample was used to estimate the frequency and outcomes of PE in adults with CKD and ESRD. Hospitalizations for the principal diagnosis of PE and presence of CKD or ESRD were identified using International Classification of Diseases, Ninth Revision codes. Data from the annual US Census and US Renal Data System reports were used to calculate the number of adults with CKD, ESRD, and normal kidney function (NKF) as well as the annual incidence of PE in each group. Logistic regression modeling was used to compare in-hospital mortality among persons admitted for PE who had ESRD or CKD to those without these conditions. ResultsThe annual frequency of PE was 527 per 100,000, 204 per 100,000, and 66 per 100,000 persons with ESRD, CKD, and NKF, respectively. In-hospital mortality was higher for persons with ESRD and CKD (P,0.001) compared with persons with NKF. Median length of stay was longer by 1 day in CKD and 2 days in ESRD than among those with NKF.Conclusions Persons with CKD and ESRD are more likely to have PE than persons with NKF. Once they have PE, they are more likely to die in the hospital.

Outcomes of In-Hospital Cardiopulmonary Resuscitation in Maintenance Dialysis Patients

“…This index uses 17 comorbid conditions with differential weighting and total scores ranging from 0 to 33, with higher scores representing greater comorbidity burden. In accordance with the previous literature, 27 we excluded kidney disease when calculating the index because that was already included as patient characteristic. Patients were also categorized based on insurance status into Medicare/Medicaid, private/health maintenance organization, or no insurance.…”

Nontraumatic Subarachnoid Hemorrhage in Maintenance Dialysis Hospitalizations

“…14 Patients with diagnosis codes for head trauma (ICD-9-CM codes 800.0-804.9, 850.0-854.1, and 873.0-873.9) and cerebrovascular malformations (747.81) were excluded. In accordance with previous literature, 15 maintenance dialysis status was defined as patients with an ICD-9-CM code for end-stage renal disease (585.6) or procedure code for hemodialysis (39.95) or peritoneal dialysis (54.98) but absence of ICD-9-CM code for acute kidney injury (584.X). Since the ICD-9-CM code for end-stage renal disease (585.…”

Acute pulmonary thromboembolism occurring during treatment with tolvaptan in a patient with autosomal-dominant polycystic kidney disease

“…Moreover, elevated hematocrit levels are reported to promote activation of factor IX (an intrinsic factor for coagulation cascade) by erythroelastase IX (factor IX-activating enzyme) in erythrocytes, which could further enhance the coagulation pathway [5,6]. In addition, patients with reduced renal function are more likely to develop pulmonary thromboembolism than those with normal kidney function [7]. Possible mechanisms for the phenomenon include enhanced activation of factor XIIa, factor VIIa, and fibrinogen, as well as inhibition of von Willebrand factor and tissue plasminogen activator in the patients with reduced renal function [8,9].…”